Consider using opioids to treat restless legs syndrome in patients who have become refractory or intolerant to other treatments
- 42 Downloads
Although initially effective in treating restless legs syndrome (RLS), some treatments, such as dopamine agonists, eventually lose efficacy and may worsen RLS symptoms. According to current evidence, opioids are effective, and may be an appropriate option for treating patients with refractory RLS or those who cannot tolerant other treatments, given that the potential risk factors involved are carefully considered.
Compliance with ethical standards
Conflict of interest
The article was adapted from Drugs 2017;77(12):1337-44  by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
The preparation of this review was not supported by any external funding.
- 2.Garcia-Borreguero D, Kohnen R, Silber MH, et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med. 2013;14(7):675–84.CrossRefPubMedGoogle Scholar
- 12.Trenkwalder C, Benes H, Grote L, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12(12):1141–50.CrossRefPubMedGoogle Scholar
- 16.Garcia-Borreguero D, Silber MH, Winkelman JW, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 2016;21:1–11.CrossRefPubMedGoogle Scholar
- 17.Winkelman JW, Armstrong MJ, Allen RP, et al. Practice guideline summary: treatment of restless legs syndrome in adults. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016;87(24):2585–93.CrossRefPubMedPubMedCentralGoogle Scholar